Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Oregon Health & Science University · Sinclair Dermatology · +16 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
480
total citations
- FWCI
- 42.93
- Percentile
- 100%
- References
- 29
Citations per year
Authors
17Topics & keywords
Topics
Keywords
- Eczema Area and Severity Index
- Medicine
- Atopic dermatitis
- Placebo
- Adverse effect
- Randomized controlled trial
- Internal medicine
- Clinical trial
No related works found for this paper.